Avoro Capital Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $860M | Sell |
|
|||||
|
2025
Q1 | $813M | Buy |
|
|||||
|
2024
Q4 | $703M | Buy |
|
|||||
|
2024
Q3 | $745M | Buy |
|
|||||
|
2024
Q2 | $572M | Buy |
|
|||||
|
2024
Q1 | $600M | Buy |
|
|||||
|
2023
Q4 | $473M | Buy |
|
|||||
|
2023
Q3 | $344M | Buy |
|
|||||
|
2023
Q2 | $320M | Buy |
|
|||||
|
2023
Q1 | $357M | Buy |
|
|||||
|
2022
Q4 | $379M | Buy |
|
|||||
|
2022
Q3 | $294M | Buy |
|
|||||
|
2022
Q2 | $211M | Buy |
|
|||||
|
2022
Q1 | $258M | Buy |
|
|||||
|
2021
Q4 | $269M | Buy |
|
|||||
|
2021
Q3 | $316M | Buy |
|
|||||
|
2021
Q2 | $250M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $300M | Hold |
|
|||||
|
2020
Q3 | $278M | Buy |
|
|||||
|
2020
Q2 | $259M | Sell |
|
|||||
|
2020
Q1 | $201M | Sell |
|
|||||
|
2019
Q4 | $259M | Sell |
|
|||||
|
2019
Q3 | $190M | Hold |
|
|||||
|
2019
Q2 | $227M | Buy |
|
|||||
|
2019
Q1 | $211M | Sell |
|
|||||
|
2018
Q4 | $124M | Buy |
|
|||||
|
2018
Q3 | $139M | Sell |
|
|||||
|
2018
Q2 | $137M | Hold |
|
|||||
|
2018
Q1 | $135M | Buy |
|
|||||
|
2017
Q4 | $67.3M | Buy |
|
|||||
|
2017
Q3 | $59.3M | Buy |
|
|||||
|
2017
Q2 | $27.5M | Buy |
|
|||||
|
2017
Q1 | $19.6M | Buy |
|
|||||
|
2016
Q4 | $11M | Buy |
|
|||||
|
2016
Q3 | $909K | Buy |
|